Eating Disorders News and Research

Latest Eating Disorders News and Research

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

Celgene International Sàrl was notified today that the E.U. Committee for Medicinal Products for Human Use (CHMP), on behalf of the European Medicines Agency (EMA) has concluded an Article 20 review of REVLIMID and issued a positive opinion for the use of REVLIMID in combination with dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

23 Sep 2011

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

Pfizer Oncology announced today that data evaluating crizotinib in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), as well as data from Pfizer's renal cell carcinoma (RCC) portfolio on axitinib, an investigational compound, and SUTENT(sunitinib malate) will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23 - 27, 2011.

14 Sep 2011

AHRQ finds decline in hospitalizations for pica eating disorder between 2007-2009

Eating disorders as the primary reason for entering the hospital declined by 23 percent from 2007 and 2009, after a steep and steady increase from 1999 to 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

12 Sep 2011

HJF selects three promising USU doctoral students to receive 2011-12 fellowships

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has selected three promising Uniformed Services University of the Health Sciences (USU) doctoral students to receive fellowships for the 2011-12 academic year.

9 Sep 2011

Roundup: Calif. ruling may extend mental health coverage; Conn. dropping early intervention program; Alaska clinic focuses on Medicare patients

A Northern California woman's treatment for anorexia at a residential facility was medically necessary and must be covered by her healthcare plan, a federal appeals court has ruled in a case that could lead to more extensive benefits for those being treated for mental illnesses.

30 Aug 2011

First Edition: August 29, 2011

Kaiser Health News staff writer Christopher Weaver, working in collaboration with The Washington Post, writes: "The federal health law calls for a huge expansion of the Medicaid program in 2014 - a potential bonanza for insurers if the law survives court challenges and opposition by Republican contenders for the White House. The expansion will add 16 million enrollees, mostly in private plans, bringing the total nationwide to about 65 million and raising the stakes for controlling costs. As budgetary pressure rises, states are increasingly passing it on to private plans".

29 Aug 2011

Leucine may help people burn fat during periods of food restriction

Research on Mt. Everest climbers is adding to the evidence that an amino acid called leucine - found in foods, dietary supplements, energy bars and other products - may help people burn fat during periods of food restriction, such as climbing at high altitude, while keeping their muscle tissue.

29 Aug 2011

Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company currently developing a nasal spray for the treatment of overweight and obese patients with Binge Eating Disorder, today announced that its patient testing stage of the Phase II clinical trials will start August 26th, 2011

25 Aug 2011

Obesity a brain condition, not just a lifestyle disorder, research confirms

New Australian research has confirmed that obese individuals often perform poorly in reasoning and planning tasks and, likewise, those with poor cognitive function are more vulnerable to excessive weight gain.

23 Aug 2011

Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia

Helsinn, a Swiss-based pharmaceutical company, announced today that its US subsidiary, Helsinn Therapeutics, has enrolled the first patient in the company's pivotal Phase III clinical program of anamorelin HCl for the treatment of anorexia/cachexia in patients with advanced non-small cell lung cancer.

23 Aug 2011

Integrated treatment approach could save lives of women with addiction

Timberline Knolls Residential Treatment Center reports people suffering from addiction rarely, if ever, have just substance abuse or addiction issues. Most addicts have trauma histories, many have mood and/or anxiety disorders, and up to 50 percent of women with substance abuse disorder have co-occurring eating disorders.

9 Aug 2011

EDRP offers free family counseling to combat eating disorders in adolescents

In an effort to combat eating disorders among adolescents, the Eating Disorder Research Program (EDRP) at University of the Sciences is offering free treatment for families with an adolescent who struggles with eating and weight concerns.

9 Aug 2011

ADA releases new position paper, 'Nutrition Intervention in the Treatment of Eating Disorders'

As one of the most complicated sets of illnesses to treat, eating disorders have mental health, as well as medical and nutritional, aspects. While treatment by a multidisciplinary health-care team is considered the best practice, there is considerable debate over how to most effectively treat eating disorders and who should be on a treatment team.

2 Aug 2011

Cost/benefit analysis shows net savings for obesity and eating disorders

Teaching middle-school children about nutrition and exercise and encouraging them to watch less TV can save the health care system a substantial amount of money, suggests an economic analysis from Children's Hospital Boston and the Centers for Disease Control and Prevention.

2 Aug 2011

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Soligenix, Inc., a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. for the development and commercialization of orBec into the European territory.

29 Jul 2011

Scientists identify possible genetic variations linked to eating disorders

A substantial number of people with eating disorders, such as anorexia nervosa have a chronic course. They are severely underweight and have a high likelihood of dying from malnutrition. No treatment has been found that helps people who are chronically ill. Now, a new study sheds light on the reason that some people have poor outcome.

27 Jul 2011

More men with eating disorders than previously thought

UK National Health Service (NHS) figures showing a 66 percent rise in hospital admissions for men with eating disorders in England over the last 10 years are just the “tip of the iceberg,” a UK charity said Wednesday.

13 Jul 2011

Clinical symptoms of food addiction are similar to symptoms of drug addiction

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that people can become dependent on highly palatable foods and engage in a compulsive pattern of consumption, similar to the behaviors we observe in drug addicts and those with alcoholism.

13 Jul 2011

Eating disorder behavior may directly affect brain function

Bulimia nervosa is a severe eating disorder associated with episodic binge eating followed by extreme behaviors to avoid weight gain such as self-induced vomiting, use of laxatives or excessive exercise.

12 Jul 2011

Onconova, SymBio enter commercialization collaboration for rigosertib in Japan and Korea

Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.

8 Jul 2011

Eating Disorders News and Research

Latest Eating Disorders News and Research

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

AHRQ finds decline in hospitalizations for pica eating disorder between 2007-2009

HJF selects three promising USU doctoral students to receive 2011-12 fellowships

Roundup: Calif. ruling may extend mental health coverage; Conn. dropping early intervention program; Alaska clinic focuses on Medicare patients

First Edition: August 29, 2011

Leucine may help people burn fat during periods of food restriction

Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder

Obesity a brain condition, not just a lifestyle disorder, research confirms

Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia

Integrated treatment approach could save lives of women with addiction

EDRP offers free family counseling to combat eating disorders in adolescents

ADA releases new position paper, 'Nutrition Intervention in the Treatment of Eating Disorders'

Cost/benefit analysis shows net savings for obesity and eating disorders

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Scientists identify possible genetic variations linked to eating disorders

More men with eating disorders than previously thought

Clinical symptoms of food addiction are similar to symptoms of drug addiction

Eating disorder behavior may directly affect brain function

Onconova, SymBio enter commercialization collaboration for rigosertib in Japan and Korea

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Eating Disorders News and Research

Latest Eating Disorders News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in